Baidu
map

哪些患者适合做卵巢去势手术?

2021-07-07 MedSci原创 MedSci原创

推荐什么样的年轻乳腺癌患者卵巢去势手术?

《梅斯直播课:3天乳腺癌诊疗训练营》
06.25-年轻乳腺癌的治疗要点及生育管理
回答问题9:请问目前您怎么看待卵巢去势手术?主要目标人群是什么?什么样的年轻乳腺癌患者您会推荐卵巢去势手术?

 

欢迎点赞、评论、分享

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=998244, encodeId=b75f998244af, content=理学诊疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:19:15 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997311, encodeId=92ef99e3115b, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Jul 07 21:19:34 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997310, encodeId=4b7b99e3104b, content=学以致用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5543479, createdName=戴和平, createdTime=Wed Jul 07 21:16:14 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997282, encodeId=f09299e28264, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74035339828, createdName=ms8000000159473599, createdTime=Wed Jul 07 20:25:35 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997267, encodeId=c6ad99e2677d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 07 18:40:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-10 ms3000001999514966

    理学诊疗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=998244, encodeId=b75f998244af, content=理学诊疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:19:15 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997311, encodeId=92ef99e3115b, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Jul 07 21:19:34 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997310, encodeId=4b7b99e3104b, content=学以致用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5543479, createdName=戴和平, createdTime=Wed Jul 07 21:16:14 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997282, encodeId=f09299e28264, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74035339828, createdName=ms8000000159473599, createdTime=Wed Jul 07 20:25:35 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997267, encodeId=c6ad99e2677d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 07 18:40:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 ms5000000518166734

    已读,真是受益匪浅呀!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=998244, encodeId=b75f998244af, content=理学诊疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:19:15 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997311, encodeId=92ef99e3115b, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Jul 07 21:19:34 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997310, encodeId=4b7b99e3104b, content=学以致用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5543479, createdName=戴和平, createdTime=Wed Jul 07 21:16:14 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997282, encodeId=f09299e28264, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74035339828, createdName=ms8000000159473599, createdTime=Wed Jul 07 20:25:35 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997267, encodeId=c6ad99e2677d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 07 18:40:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 戴和平

    学以致用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=998244, encodeId=b75f998244af, content=理学诊疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:19:15 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997311, encodeId=92ef99e3115b, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Jul 07 21:19:34 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997310, encodeId=4b7b99e3104b, content=学以致用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5543479, createdName=戴和平, createdTime=Wed Jul 07 21:16:14 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997282, encodeId=f09299e28264, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74035339828, createdName=ms8000000159473599, createdTime=Wed Jul 07 20:25:35 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997267, encodeId=c6ad99e2677d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 07 18:40:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 ms8000000159473599

    认真学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=998244, encodeId=b75f998244af, content=理学诊疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:19:15 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997311, encodeId=92ef99e3115b, content=已读,真是受益匪浅呀!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f03a5433387, createdName=ms5000000518166734, createdTime=Wed Jul 07 21:19:34 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997310, encodeId=4b7b99e3104b, content=学以致用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5543479, createdName=戴和平, createdTime=Wed Jul 07 21:16:14 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997282, encodeId=f09299e28264, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74035339828, createdName=ms8000000159473599, createdTime=Wed Jul 07 20:25:35 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997267, encodeId=c6ad99e2677d, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Wed Jul 07 18:40:41 CST 2021, time=2021-07-07, status=1, ipAttribution=)]
    2021-07-07 医鸣惊人

    认真学习了

    0

相关资讯

年轻乳腺癌的肿瘤特征是什么?复发风险和预后有何特点?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

BRCA1/2突变的年轻患者是否适宜保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

阳性且有转移的乳腺癌患者是只能注射靶向药治疗吗?

《梅斯直播课:3天乳腺癌诊疗训练营》 06.25-年轻乳腺癌的治疗要点及生育管理 回答问题6:阳性且有转移的治疗是只能一直打靶向药么?

年轻乳腺癌ofs+AI后仍未绝经,后续如何进行内分泌治疗?

年轻乳腺癌ofs+AI后仍未绝经,后续如何内分泌治疗?

乳腺癌患者注射紫杉醇会影响月经吗?

乳腺癌患者注射紫杉醇会影响月经吗?

年轻乳腺癌应选择乳房切除术还是保乳手术?

《梅斯直播课:3天乳腺癌诊疗训练营》06.25-年轻乳腺癌的治疗要点及生育管理

拓展阅读

姜鸿南教授:乳腺癌患者卵巢去势治疗的风云变幻

随着时代的发展和国民经济水平的提升,乳腺癌逐渐成为危害我国女性健康的第一位恶性肿瘤。从2019年国家公布的恶性肿瘤发病率看,乳腺癌的粗发病率为45.29/10万。且我国的乳腺癌发病年龄高峰有别于西方国

Baidu
map
Baidu
map
Baidu
map